Anti-Neoplastic Agents Market Size, Share, Trends, Growth and Forecast 2032
Anti-Neoplastic Agents Market By Product Type (Targeted Therapy, Chemotherapy, Hormonal Therapy (Biologic Therapy), Immunotherapy, and Others), By End-Users/Application (Breast Cancer, Blood Cancer, Prostate Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, and Other Cancers), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 11.10 Billion | USD 27.12 Billion | 10.56% | 2023 |
Table Of Content
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Anti-Neoplastic Agents Market, 2016–2026 (USD Billion)
- 2.2. Anti-Neoplastic Agents Market: Snapshot
- Chapter 3. Global Anti-Neoplastic Agents Market– Industry Analysis
- 3.1. Anti-Neoplastic Agents Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Breakthroughs in the personalized medicine domain are predicted to offer new growth avenues for the anti-neoplastic agents industry over the forecast timeline.
- 3.2.2. These drugs are utilized in combination with other drug treatments in radiotherapies, surgeries, hormone therapies, and other various targeted therapies and this will drive the market trends.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
- 3.4.1. Market attractiveness analysis By Product
- 3.4.2. Market attractiveness analysis By End-Users/ Application
- Chapter 4. Global Anti-Neoplastic Agents Market– Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Anti-Neoplastic Agents Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Anti-Neoplastic Agents Market– Product Analysis
- 5.1. Global Anti-Neoplastic Agents Market overview: By Product
- 5.1.1. Global Anti-Neoplastic Agents Market Share, By Product, 2019 and 2026
- 5.2. Targeted Therapy
- 5.2.1. Global Anti-Neoplastic Agents Market by Targeted Therapy, 2016–2026 (USD Billion)
- 5.3. Chemotherapy
- 5.3.1. Global Anti-Neoplastic Agents Market by Chemotherapy, 2016–2026 (USD Billion)
- 5.4. Hormonal Therapy
- 5.4.1. Global Anti-Neoplastic Agents Market by Hormonal Therapy , 2016–2026 (USD Billion)
- 5.5. Immunotherapy
- 5.5.1. Global Anti-Neoplastic Agents Market by Immunotherapy , 2016–2026 (USD Billion)
- 5.6. Others
- 5.6.1. Global Anti-Neoplastic Agents Market by Others, 2016–2026 (USD Billion)
- 5.1. Global Anti-Neoplastic Agents Market overview: By Product
- Chapter 6. Global Anti-Neoplastic Agents Market– End-Users/ Application Analysis
- 6.1. Global Anti-Neoplastic Agents Market overview: By End-Users/ Application
- 6.1.1. Global Anti-Neoplastic Agents Market Share, By End-Users/ Application, 2019 and 2026
- 6.2. Breast Cancer
- 6.2.1. Global Anti-Neoplastic Agents Market by Breast Cancer , 2016–2026 (USD Billion)
- 6.3. Blood Cancer
- 6.3.1. Global Anti-Neoplastic Agents Market by Blood Cancer, 2016–2026 (USD Billion)
- 6.4. Prostate Cancer
- 6.4.1. Global Anti-Neoplastic Agents Market by Prostate Cancer, 2016–2026 (USD Billion)
- 6.5. Gastrointestinal Cancer
- 6.5.1. Global Anti-Neoplastic Agents Market by Gastrointestinal Cancer, 2016–2026 (USD Billion)
- 6.6. Respiratory/Lung Cancer
- 6.6.1. Global Anti-Neoplastic Agents Market by Respiratory/Lung Cancer, 2016–2026 (USD Billion)
- 6.7. Other Cancers
- 6.7.1. Global Anti-Neoplastic Agents Market by Other Cancers, 2016–2026 (USD Billion)
- 6.1. Global Anti-Neoplastic Agents Market overview: By End-Users/ Application
- Chapter 7. Company Profiles
- 7.1. Teva pharmaceutical Industries Ltd.
- 7.1.1. Overview
- 7.1.2. Financials
- 7.1.3. Product Portfolio
- 7.1.4. Business Strategy
- 7.1.5. Recent Developments
- 7.2. Amgen Inc.
- 7.2.1. Overview
- 7.2.2. Financials
- 7.2.3. Product Portfolio
- 7.2.4. Business Strategy
- 7.2.5. Recent Developments
- 7.3. Hoffmann-La Roche Ltd.
- 7.3.1. Overview
- 7.3.2. Financials
- 7.3.3. Product Portfolio
- 7.3.4. Business Strategy
- 7.3.5. Recent Developments
- 7.4. Bristul-Myers Squibb Company
- 7.4.1. Overview
- 7.4.2. Financials
- 7.4.3. Product Portfolio
- 7.4.4. Business Strategy
- 7.4.5. Recent Developments
- 7.5. Aspen Global Inc.
- 7.5.1. Overview
- 7.5.2. Financials
- 7.5.3. Product Portfolio
- 7.5.4. Business Strategy
- 7.5.5. Recent Development
- 7.6. Boehringer Ingelheim GmbH
- 7.6.1. Overview
- 7.6.2. Financials
- 7.6.3. Product Portfolio
- 7.6.4. Business Strategy
- 7.6.5. Recent Development
- 7.7. Bayer AG
- 7.7.1. Overview
- 7.7.2. Financials
- 7.7.3. Product Portfolio
- 7.7.4. Business Strategy
- 7.7.5. Recent Development
- 7.8. Merc & Co., Inc.
- 7.8.1. Overview
- 7.8.2. Financials
- 7.8.3. Product Portfolio
- 7.8.4. Business Strategy
- 7.8.5. Recent Development
- 7.9. Johnson & Johnson Pvt. Ltd.
- 7.9.1. Overview
- 7.9.2. Financials
- 7.9.3. Product Portfolio
- 7.9.4. Business Strategy
- 7.9.5. Recent Development
- 7.10. Baxter Healthcare Corporation
- 7.10.1. Overview
- 7.10.2. Financials
- 7.10.3. Product Portfolio
- 7.10.4. Business Strategy
- 7.10.5. Recent Development
- 7.11. Accord Healthcare, Inc.
- 7.11.1. Overview
- 7.11.2. Financials
- 7.11.3. Product Portfolio
- 7.11.4. Business Strategy
- 7.11.5. Recent Development
- 7.12. Pfizer Inc.
- 7.12.1. Overview
- 7.12.2. Financials
- 7.12.3. Product Portfolio
- 7.12.4. Business Strategy
- 7.12.5. Recent Development
- 7.13. Lundbeck LLC
- 7.13.1. Overview
- 7.13.2. Financials
- 7.13.3. Product Portfolio
- 7.13.4. Business Strategy
- 7.13.5. Recent Development
- 7.14. Genentech, Inc.
- 7.14.1. Overview
- 7.14.2. Financials
- 7.14.3. Product Portfolio
- 7.14.4. Business Strategy
- 7.14.5. Recent Development
- 7.15. AbbVie Inc.
- 7.15.1. Overview
- 7.15.2. Financials
- 7.15.3. Product Portfolio
- 7.15.4. Business Strategy
- 7.15.5. Recent Development
- 7.1. Teva pharmaceutical Industries Ltd.
Table Of Figures
List of Figures
1. Market research process
2. Market research methodology
3. Global Anti-Neoplastic Agents Market, 2016–2026 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global Anti-Neoplastic Agents Market attractiveness, By Product
6. Global Anti-Neoplastic Agents Market attractiveness, By End-Users/ Application
7. Global Anti-Neoplastic Agents Market Share by Product,2019 and 2026 (USD Billion)
8. Global Anti-Neoplastic Agents Market by Targeted Therapy,2016–2026 (USD Billion)
9. Global Anti-Neoplastic Agents Market by Chemotherapy ,2016–2026 (USD Billion)
10. Global Anti-Neoplastic Agents Market by Hormonal Therapy ,2016–2026 (USD Billion)
11. Global Anti-Neoplastic Agents Market Share By End-Users/ Application,2019 and 2026 (USD Billion)
12. Global Anti-Neoplastic Agents Market by Breast Cancer ,2016–2026 (USD Billion)
13. Global Anti-Neoplastic Agents Market, By Blood Cancer, 2016–2026 (USD Billion)
14. Global Anti-Neoplastic Agents Market by Prostate Cancer,2016–2026 (USD Billion)
15. Global Anti-Neoplastic Agents Market by Gastrointestinal Cancer,2016–2026 (USD Billion)
16. Global Anti-Neoplastic Agents Market by Respiratory/Lung Cancer,2016–2026 (USD Billion)
17. Global Anti-Neoplastic Agents Market by Other Cancers,2016–2026 (USD Billion)
18. Global Anti-Neoplastic Agents Market Share, by Region, 2019 and 2026
19. North America Anti-Neoplastic Agents Market, 2016–2026 (USD Billion)
20. Europe Anti-Neoplastic Agents Market, 2016–2026 (USD Billion)
21. Asia Pacific Anti-Neoplastic Agents Market, 2016–2026 (USD Billion)
22. Latin America Anti-Neoplastic Agents Market, 2016–2026 (USD Billion)
23. The Middle East and Africa Anti-Neoplastic Agents Market, 2016–2026 (USD Billion)
Table Of Tables
List of Tables
1. Global Anti-Neoplastic Agents Market: snapshot
2. Drivers of the Anti-Neoplastic Agents Market: impact analysis
3. North America Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
4. North America Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
5. The U.S. Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
6. The U.S. Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
7. Rest of North America Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
8. Rest of North America Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
9. Europe Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
10. Europe Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
11. UK Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
12. UK Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
13. France Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
14. France Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
15. Germany Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
16. Germany Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
17. Rest of Europe Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
18. Rest of Europe Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
19. Asia Pacific Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
20. Asia Pacific Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
21. China Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
22. China Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
23. Japan Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
24. Japan Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
25. India Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
26. India Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
27. Rest of Asia Pacific Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
28. Rest of Asia Pacific Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
29. Latin America Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
30. Latin America Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
31. Brazil Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
32. Brazil Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
33. Rest of Latin America Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
34. Rest of Latin America Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
35. The Middle East and Africa Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
36. The Middle East and Africa Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
37. Saudi Arabia Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
38. Saudi Arabia Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
39. South Africa Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
40. South Africa Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
41. Rest of the Middle East & Africa Anti-Neoplastic Agents Market revenue, By Product, 2016–2026 (USD Billion)
42. Rest of the Middle East & Africa Anti-Neoplastic Agents Market revenue, By End-Users/ Application, 2016–2026 (USD Billion)
Methodology
FrequentlyAsked Questions
The growth of the market over the estimated timespan is attributed to growing cases of cancer along with demand for cost-efficient therapies. Breakthroughs in the personalized medicine domain are predicted to offer new growth avenues for the anti-neoplastic agents industry over the forecast timeline. These drugs are utilized in combination with other drug treatments in radiotherapies, surgeries, hormone therapies, and other various targeted therapies and this will drive the market trends.
global Anti-Neoplastic Agents Market was worth USD 11.10 Billion in 2023. The market is forecast to reach USD 27.12 Billion by 2032, growing at a compound annual growth rate (CAGR) of 10.56% during the forecast period 2024-2032
North America is likely to make noteworthy contributions towards overall market revenue. The growth of the regional market over the estimated timespan is attributed to growing use of anti-cancer drug therapies in the countries like the U.S. and Canada. In addition to this, presence of strong healthcare infrastructure and number of non-government institutes providing cancer management services will proliferate the regional market growth. Apparently, huge occurrence of the chronic ailments and unhealthy diet as well as disorganized lifestyle along with lack of time management and busy lifestyle or hectic work will increase the demand for the product in the healthcare sector across the region in the near future.
The key players profiled in the report include Merck & Co., Inc.; Teva pharmaceutical Industries Ltd.; Genentech, Inc.; Amgen Inc.; Pfizer Inc.; Bristol-Myers Squibb Company; Accord Healthcare, Inc.; Baxter Healthcare Corporation; Aspen Global Inc.; Boehringer Ingelheim GmbH; Bayer AG; Hoffmann-La Roche Ltd.; Johnson & Johnson Pvt. Ltd.; Lundbeck LLC; and AbbVie Inc.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed